COMPASS Pathways shares are trading higher after Morgan Stanley initiated coverage on the stock with an Overweight rating and announced a $30 price target.
Portfolio Pulse from Benzinga Newsdesk
COMPASS Pathways shares surged following Morgan Stanley's initiation of coverage with an Overweight rating and a $30 price target.

April 01, 2024 | 6:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
COMPASS Pathways shares experienced a significant increase after Morgan Stanley initiated coverage with an Overweight rating and a $30 price target.
The initiation of coverage by a major financial institution like Morgan Stanley, especially with an Overweight rating and a specific price target, typically leads to increased investor interest and confidence in the stock. This often results in a short-term price increase as investors adjust their positions based on the new information.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100